MHB018A

DRUG2 trials

Sponsors

Minghui Pharmaceutical (Hangzhou) Ltd

Conditions

Thyroid Associated OphthalmopathiesThyroid Eye Disease, TED

Phase 3

MHB018A Treatment in Patients With Active Thyroid Eye Disease

RecruitingNCT06989918

Minghui Pharmaceutical (Hangzhou) LtdThyroid Associated Ophthalmopathies

Start: 2025-07-22End: 2027-07-31Target: 108Updated: 2026-04-02

Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study

Not yet recruitingNCT07622108

Minghui Pharmaceutical (Hangzhou) LtdThyroid Eye Disease, TED

Start: 2026-12-01End: 2029-07-01Target: 84Updated: 2026-06-04